Search
for
Sort by
Research 421–450 of 1000+
- Effect of ethanol extract of Zapoteca portoricensis stem on liver, kidney and prostatic biomarkers of testosterone-induced benign prostate hyperplasia (BPH) in male albino rats
- IMPACT OF LOW DOSE FINASTERIDE FOR THE TREATMENT OF ANDROGENIC ALOPECIA ON SERUM PROSTATE SPECIFIC ANTIGEN (PSA) LEVELS IN MEN PARTICIPATED IN POPULATION-BASED SCREENING FOR PROSTATE CANCER
- The Risks and Benefits of 5α-Reductase Inhibitors for Prostate-Cancer Prevention
- Sex differences in SARS-CoV-2 infection rates and the potential link to prostate cancer
- The Transcriptional Co-Activator cAMP Response Element-Binding Protein-Binding Protein Is Expressed in Prostate Cancer and Enhances Androgen- and Anti-Androgen-Induced Androgen Receptor Function
- Prostate Carcinoma, what would be the best to do ?
- Male pattern baldness and the risk of prostate cancer
- Finasteride Inhibits Human Prostate Cancer Cell Invasion through MMP2 and MMP9 Downregulation
- The Dark Side of 5α-Reductase Inhibitors' Therapy: Sexual Dysfunction, High Gleason Grade Prostate Cancer and Depression
- 5α- Reductase Inhibitors in Prostate Cancer: An Overview
- Early-onset baldness and the risk of aggressive prostate cancer: findings from a case–control study
- Incidence of liver toxicity associated with the use of flutamide in prostate cancer patients
- Anti-proliferative effect of terpenes on human prostate cáncer cells: natural sources and their potential role as chemopreventive agents.
- Association Between 5α-Reductase Inhibitors and Prostate Cancer Mortality
- RE: EFFECT OF THE DUAL 5α-REDUCTASE INHIBITOR DUTASTERIDE ON MARKERS OF TUMOR REGRESSION IN PROSTATE CANCER
- Synthesis and Structure–Activity Relationships of the First Ferrocenyl-Aryl-Hydantoin Derivatives of the Nonsteroidal Antiandrogen Nilutamide
- Cardiovascular effects of hormone therapy for prostate cancer
- Clinical Management of Prostate Cancer in High-Risk Genetic Mutation Carriers
- Anti-cancer properties of olive oil secoiridoid phenols: a systematic review of in vivo studies
- Molecular targeted therapies for cancer: Sorafenib mono�therapy and its combination with other therapies (Review)
- The Relationship Between Metformin and Serum Prostate‐Specific Antigen Levels
- A Chance Finding of High Grade Prostate Cancer in a 35-Year-Old Male – A Case Report and Outcomes of Robotic Radical Prostatectomy in Young Men with Prostate Cancer
- Testosterone Deficiency is Not Protective Against the Development of Adenocarcinoma of the Prostate in a Type 1 Diabetic Patient
- Metastatic Embryonal Cell Carcinoma with High Testosterone and Absence of Secondary Sexual Characteristics
- Male pattern baldness and prostate cancer risk in a population-based case–control study
- Androgenetic alopecia and prostate cancer: findings from an Australian case-control study.
- Rare Germline Pathogenic Variants Identified by Multigene Panel Testing and the Risk of Aggressive Prostate Cancer
- Clinical characterization of men with long QT syndrome and torsades de pointes associated with hypogonadism: A review and pharmacovigilance study
- Role of 5 alpha-reductase inhibitors in the management of prostate cancer
- Clinical Pearls in Men's Health